1647 related articles for article (PubMed ID: 20692795)
1. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
2. Invited commentary.
Rzucidlo EM
J Vasc Surg; 2010 Nov; 52(5):1300. PubMed ID: 21050989
[No Abstract] [Full Text] [Related]
3. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.
Ou HC; Song TY; Yeh YC; Huang CY; Yang SF; Chiu TH; Tsai KL; Chen KL; Wu YJ; Tsai CS; Chang LY; Kuo WW; Lee SD
J Appl Physiol (1985); 2010 Jun; 108(6):1745-56. PubMed ID: 20203069
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.
Ou HC; Lee WJ; Lee SD; Huang CY; Chiu TH; Tsai KL; Hsu WC; Sheu WH
Toxicol Appl Pharmacol; 2010 Oct; 248(2):134-43. PubMed ID: 20691200
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway.
Ou HC; Chou WC; Hung CH; Chu PM; Hsieh PL; Chan SH; Tsai KL
Environ Toxicol; 2019 Jul; 34(7):825-835. PubMed ID: 30963716
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway.
Tsai KL; Chen LH; Chiou SH; Chiou GY; Chen YC; Chou HY; Chen LK; Chen HY; Chiu TH; Tsai CS; Ou HC; Kao CL
Mol Nutr Food Res; 2011 Sep; 55 Suppl 2():S227-40. PubMed ID: 21812107
[TBL] [Abstract][Full Text] [Related]
7. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.
Bao MH; Zhang YW; Lou XY; Xiao Y; Cheng Y; Zhou HH
Can J Physiol Pharmacol; 2014 Apr; 92(4):299-306. PubMed ID: 24708212
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells.
Kuo MY; Ou HC; Lee WJ; Kuo WW; Hwang LL; Song TY; Huang CY; Chiu TH; Tsai KL; Tsai CS; Sheu WH
J Agric Food Chem; 2011 May; 59(9):5100-8. PubMed ID: 21480623
[TBL] [Abstract][Full Text] [Related]
9. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba extract attenuates oxLDL-induced endothelial dysfunction via an AMPK-dependent mechanism.
Ou HC; Hsieh YL; Yang NC; Tsai KL; Chen KL; Tsai CS; Chen IJ; Wu BT; Lee SD
J Appl Physiol (1985); 2013 Jan; 114(2):274-85. PubMed ID: 23195633
[TBL] [Abstract][Full Text] [Related]
11. Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling.
Ou HC; Lee WJ; Wu CM; Chen JF; Sheu WH
J Vasc Surg; 2012 Apr; 55(4):1104-15. PubMed ID: 22244860
[TBL] [Abstract][Full Text] [Related]
12. Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin.
Caliceti C; Rizzo P; Ferrari R; Fortini F; Aquila G; Leoncini E; Zambonin L; Rizzo B; Calabria D; Simoni P; Mirasoli M; Guardigli M; Hrelia S; Roda A; Cicero AFG
Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):552-563. PubMed ID: 28511903
[TBL] [Abstract][Full Text] [Related]
13. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells.
Jiang JX; Zhang SJ; Liu YN; Lin XX; Sun YH; Shen HJ; Yan XF; Xie QM
Eur J Pharmacol; 2014 Mar; 727():43-51. PubMed ID: 24486707
[TBL] [Abstract][Full Text] [Related]
14. Chicoric acid is a potent anti-atherosclerotic ingredient by anti-oxidant action and anti-inflammation capacity.
Tsai KL; Kao CL; Hung CH; Cheng YH; Lin HC; Chu PM
Oncotarget; 2017 May; 8(18):29600-29612. PubMed ID: 28410194
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathway.
Zhao W; Ma G; Chen X
Vascul Pharmacol; 2014 Dec; 63(3):162-72. PubMed ID: 25135647
[TBL] [Abstract][Full Text] [Related]
16. Role of LOX-1 in monocyte adhesion-triggered redox, Akt/eNOS and Ca2+ signaling pathways in endothelial cells.
Sakamoto N; Ishibashi T; Sugimoto K; Sawamura T; Sakamoto T; Inoue N; Saitoh S; Kamioka M; Uekita H; Ohkawara H; Suzuki K; Teramoto T; Maruyama Y; Takeishi Y
J Cell Physiol; 2009 Sep; 220(3):706-15. PubMed ID: 19452449
[TBL] [Abstract][Full Text] [Related]
17. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.
Taye A; Saad AH; Kumar AH; Morawietz H
Eur J Pharmacol; 2010 Feb; 627(1-3):42-8. PubMed ID: 19878672
[TBL] [Abstract][Full Text] [Related]
18. Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways.
Yao Y; Wang Y; Zhang Y; Liu C
Lipids Health Dis; 2017 Apr; 16(1):77. PubMed ID: 28407763
[TBL] [Abstract][Full Text] [Related]
19. Schisanhenol ameliorates oxLDL-caused endothelial dysfunction by inhibiting LOX-1 signaling.
Chiu TH; Ku CW; Ho TJ; Tsai KL; Yang YD; Ou HC; Chen HI
Environ Toxicol; 2023 Jul; 38(7):1589-1596. PubMed ID: 36999521
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways.
Tsai KL; Huang YH; Kao CL; Yang DM; Lee HC; Chou HY; Chen YC; Chiou GY; Chen LH; Yang YP; Chiu TH; Tsai CS; Ou HC; Chiou SH
J Nutr Biochem; 2012 May; 23(5):458-68. PubMed ID: 21684136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
